Form 4: Bristol-Myers Squibb Executive Cari Gallman Reports Stock Transactions

EVP Cari Gallman reports acquisition and disposal of Bristol-Myers Squibb common stock and restricted stock units.

Summary

• On October 2, 2024, Cari Gallman, EVP of Corporate Affairs at Bristol-Myers Squibb, reported transactions involving the company's stock.
• Gallman acquired 4,558 shares of common stock upon the vesting of restricted stock units.
• Simultaneously, 1,648 shares were withheld for payment of taxes related to the vesting of the award at a price of $53.76 per share.
• Following these transactions, Gallman directly owns 5,019 shares of common stock and 9,117 restricted stock units.
• The restricted stock units vest in three equal installments beginning on October 2, 2024, and each unit converts into one share of common stock upon vesting.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and insider ownership, which can be seen as a sign of confidence in the company.

Positives

• The vesting of restricted stock units indicates a form of compensation and alignment of the executive's interests with the company's performance.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the restricted stock units implies continued employment and alignment with the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, ensuring fair market practices.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units to align management's interests with shareholder value, a common practice among large pharmaceutical companies like Johnson & Johnson (JNJ) and Pfizer (PFE).
• The vesting schedule of three years is a standard vesting period for such awards.

Stakeholder Impact

• The transactions have a minor positive impact on shareholders by aligning executive interests with company performance.

Key Dates